Medicine and Dentistry
Adjuvant Therapy
5%
Angiogenesis
7%
Aromatase Inhibitor
20%
Biopsy
6%
Bisphosphonate
5%
Bone Density
7%
Bone Metastasis
9%
Breast Cancer
100%
Cancer Stem Cell
9%
Cancer Therapy
6%
Cell Activity
10%
Cyclooxygenase 2
7%
Epidermal Growth Factor Receptor
6%
Epithelial Cell
7%
Estrogen Receptor
9%
Exemestane
7%
Hormone Receptor
5%
Hormone Therapy
6%
In Vitro
8%
Intraductal Carcinoma
31%
Letrozole
7%
Malignant Neoplasm
10%
Mastectomy
6%
Meta-Analysis
5%
Metastatic Carcinoma
6%
Neoplasm
15%
Osteolysis
13%
Parathyroid Hormone-Related Protein
7%
Placebo
8%
Postmenopause
15%
Programmed Cell Death
9%
Prospective Cohort Study
6%
Quadrantectomy
7%
Radiation Therapy
8%
Recurrent Disease
23%
Symptom
5%
Tamoxifen
16%
Tibolone
7%
Vasculotropin
5%
Zoledronic Acid
9%
Pharmacology, Toxicology and Pharmaceutical Science
Aromatase Inhibitor
16%
Breast Cancer
45%
Cyclooxygenase 2
5%
Epidermal Growth Factor Receptor
6%
Estrogen Receptor
11%
Fulvestrant
5%
Gefitinib
5%
Intraductal Carcinoma
25%
Letrozole
6%
Malignant Neoplasm
10%
Neoplasm
12%
Placebo
8%
Progesterone Receptor
5%
Recurrent Disease
9%
Tamoxifen
15%
Zoledronic Acid
9%